L.M. Méndez-Rodríguez , L.C. Nocua-Báez , G. Mejía-Salgado , A. de-la-Torre , C.A. Álvarez-Moreno
{"title":"传染病:流行病学、病因学、诊断结果和治疗","authors":"L.M. Méndez-Rodríguez , L.C. Nocua-Báez , G. Mejía-Salgado , A. de-la-Torre , C.A. Álvarez-Moreno","doi":"10.1016/j.oftal.2025.01.010","DOIUrl":null,"url":null,"abstract":"<div><div>Infectious uveitis is an inflammation of the uveal tract, corresponding to the eye's middle layer, triggered by a response against an infectious agent. This condition is classified into anterior, intermediate, posterior and panuveitis. The most frequent infectious agents in anterior uveitis are viruses, mainly herpes simplex virus. However, it can also be caused by other pathogens such as <em>Bartonella</em> spp<em>., Mycobacterium tuberculosis</em> and <em>Fusarium</em> spp<em>.</em> In intermediate uveitis, syphilis plays a predominant role, while in posterior uveitis various microorganisms are involved, among them <em>Toxoplasma gondii, Cytomegalovirus, Plasmodium</em> spp<em>. and Candida</em> spp. In some instances, as in ocular toxoplasmosis, severe inflammation may involve the entire uvea, resulting in panuveitis.</div><div>Clinical manifestations of uveitis include ocular pain, redness, myodesopsias, blurred vision, and even vision loss. Direct identification of the causative agent is complex, and the diagnostic performance of available tests varies significantly. For example, polymerase chain reaction (PCR) on ocular specimens for Herpes simplex virus has a sensitivity of 91.3% and specificity of 98.8%, while for toxoplasmosis the sensitivity is 43.1% and specificity 98.5%. Another challenge in infectious uveitis is treatment, as systemic antimicrobials generally have a low penetration into ocular tissue, mostly less than 5%, mainly due to the blood-retinal and blood-aqueous barriers. The efficacy of the molecules in ocular tissue is favored by low protein binding and high liposolubility.</div><div>This review addresses the most frequent clinical manifestations of bacterial, viral, parasitic and fungal etiologies of infectious uveitis, as well as the diagnostic performance of available tests. In addition, emphasis is placed on the different therapeutic approaches depending on etiology.</div></div>","PeriodicalId":8348,"journal":{"name":"Archivos De La Sociedad Espanola De Oftalmologia","volume":"100 7","pages":"Pages 397-420"},"PeriodicalIF":0.0000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Uveítis infecciosa: epidemiología, etiología, rendimiento de pruebas diagnósticas y tratamiento\",\"authors\":\"L.M. Méndez-Rodríguez , L.C. Nocua-Báez , G. Mejía-Salgado , A. de-la-Torre , C.A. Álvarez-Moreno\",\"doi\":\"10.1016/j.oftal.2025.01.010\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Infectious uveitis is an inflammation of the uveal tract, corresponding to the eye's middle layer, triggered by a response against an infectious agent. This condition is classified into anterior, intermediate, posterior and panuveitis. The most frequent infectious agents in anterior uveitis are viruses, mainly herpes simplex virus. However, it can also be caused by other pathogens such as <em>Bartonella</em> spp<em>., Mycobacterium tuberculosis</em> and <em>Fusarium</em> spp<em>.</em> In intermediate uveitis, syphilis plays a predominant role, while in posterior uveitis various microorganisms are involved, among them <em>Toxoplasma gondii, Cytomegalovirus, Plasmodium</em> spp<em>. and Candida</em> spp. In some instances, as in ocular toxoplasmosis, severe inflammation may involve the entire uvea, resulting in panuveitis.</div><div>Clinical manifestations of uveitis include ocular pain, redness, myodesopsias, blurred vision, and even vision loss. Direct identification of the causative agent is complex, and the diagnostic performance of available tests varies significantly. For example, polymerase chain reaction (PCR) on ocular specimens for Herpes simplex virus has a sensitivity of 91.3% and specificity of 98.8%, while for toxoplasmosis the sensitivity is 43.1% and specificity 98.5%. Another challenge in infectious uveitis is treatment, as systemic antimicrobials generally have a low penetration into ocular tissue, mostly less than 5%, mainly due to the blood-retinal and blood-aqueous barriers. The efficacy of the molecules in ocular tissue is favored by low protein binding and high liposolubility.</div><div>This review addresses the most frequent clinical manifestations of bacterial, viral, parasitic and fungal etiologies of infectious uveitis, as well as the diagnostic performance of available tests. In addition, emphasis is placed on the different therapeutic approaches depending on etiology.</div></div>\",\"PeriodicalId\":8348,\"journal\":{\"name\":\"Archivos De La Sociedad Espanola De Oftalmologia\",\"volume\":\"100 7\",\"pages\":\"Pages 397-420\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Archivos De La Sociedad Espanola De Oftalmologia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0365669125000140\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archivos De La Sociedad Espanola De Oftalmologia","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0365669125000140","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
Uveítis infecciosa: epidemiología, etiología, rendimiento de pruebas diagnósticas y tratamiento
Infectious uveitis is an inflammation of the uveal tract, corresponding to the eye's middle layer, triggered by a response against an infectious agent. This condition is classified into anterior, intermediate, posterior and panuveitis. The most frequent infectious agents in anterior uveitis are viruses, mainly herpes simplex virus. However, it can also be caused by other pathogens such as Bartonella spp., Mycobacterium tuberculosis and Fusarium spp. In intermediate uveitis, syphilis plays a predominant role, while in posterior uveitis various microorganisms are involved, among them Toxoplasma gondii, Cytomegalovirus, Plasmodium spp. and Candida spp. In some instances, as in ocular toxoplasmosis, severe inflammation may involve the entire uvea, resulting in panuveitis.
Clinical manifestations of uveitis include ocular pain, redness, myodesopsias, blurred vision, and even vision loss. Direct identification of the causative agent is complex, and the diagnostic performance of available tests varies significantly. For example, polymerase chain reaction (PCR) on ocular specimens for Herpes simplex virus has a sensitivity of 91.3% and specificity of 98.8%, while for toxoplasmosis the sensitivity is 43.1% and specificity 98.5%. Another challenge in infectious uveitis is treatment, as systemic antimicrobials generally have a low penetration into ocular tissue, mostly less than 5%, mainly due to the blood-retinal and blood-aqueous barriers. The efficacy of the molecules in ocular tissue is favored by low protein binding and high liposolubility.
This review addresses the most frequent clinical manifestations of bacterial, viral, parasitic and fungal etiologies of infectious uveitis, as well as the diagnostic performance of available tests. In addition, emphasis is placed on the different therapeutic approaches depending on etiology.
期刊介绍:
La revista Archivos de la Sociedad Española de Oftalmología, editada mensualmente por la propia Sociedad, tiene como objetivo publicar trabajos de investigación básica y clínica como artículos originales; casos clínicos, innovaciones técnicas y correlaciones clinicopatológicas en forma de comunicaciones cortas; editoriales; revisiones; cartas al editor; comentarios de libros; información de eventos; noticias personales y anuncios comerciales, así como trabajos de temas históricos y motivos inconográficos relacionados con la Oftalmología. El título abreviado es Arch Soc Esp Oftalmol, y debe ser utilizado en bibliografías, notas a pie de página y referencias bibliográficas.